SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Garros Julio

(Last)

(First)

(Middle)

C/O BUNGE LIMITED

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD

63017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2021

3. Issuer Name and Ticker or Trading Symbol
BUNGELTD [ BG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Pres, Ag Develop, Ops & Mill

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	37,316.321⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to buy)	⁽²⁾	02/28/2022	Common Stock	1,050	$67.63	D
Stock Options (Right to buy)	⁽³⁾	03/04/2023	Common Stock	1,350	$74.33	D
Stock Options (Right to buy)	⁽⁴⁾	02/27/2024	Common Stock	3,300	$79.47	D
Stock Options (Right to buy)	⁽⁵⁾	02/26/2025	Common Stock	3,750	$81.68	D
Stock Options (Right to buy)	⁽⁶⁾	03/01/2026	Common Stock	6,500	$50.07	D
Stock Options (Right to buy)	⁽⁷⁾	03/08/2027	Common Stock	4,700	$81	D
Stock Options (Right to buy)	⁽⁸⁾	02/28/2028	Common Stock	5,800	$75.99	D
Stock Options (Right to buy)	⁽⁹⁾	03/12/2029	Common Stock	7,700	$51.89	D

Explanation of Responses:

1. Includes (i) 1,150 restricted stock units ("RSUs") that were granted to the insider on March 12, 2019 and 86 RSUs acquired pursuant to a dividend reinvestment feature that will vest on March 12, 2022, (ii) 3,450 restricted stock units ("RSUs") that were granted to the insider on March 10, 2020 and 134 RSUs acquired pursuant to a dividend reinvestment feature that will vest in two annual installments as to 33% on March 10, 2022 and 66% on March 10, 2023 and (iii) 3,100 restricted stock units ("RSUs") that were granted to the insider on March 15, 2021 that will vest 100% on March 15, 2024. One RSU is convertible into one share of the Bunge Limited stock.

2. These options became exercisable in three equal annual installments beginning on February 28, 2013.

3. These options became exercisable in three equal annual installments beginning on March 5, 2014.

4. These options became exercisable in three equal annual installments beginning on February 28, 2015.

5. These options became exercisable in three equal annual installments beginning on February 27, 2016.

6. These options became exercisable in three equal annual installments beginning on March 1, 2017.

7. These options became exercisable in three equal annual installments beginning March 8, 2018.

8. These options became exercisable in three equal annual installments beginning on February 28, 2019.

9. These options became exercisable in three equal annual installments beginning on March 12, 2020.

Remarks:

	Drew Yaeger, Attorney-in-Fact	04/07/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.